Oireachtas Joint and Select Committees

Thursday, 27 May 2021

Joint Oireachtas Committee on Finance, Public Expenditure and Reform, and Taoiseach

Protected Disclosure Legislation: Discussion

Photo of Alice-Mary HigginsAlice-Mary Higgins (Independent) | Oireachtas source

I am conscious that my time is up, but I have a very brief question that perhaps could be incorporated into later answers.

The senior executive accountability regime is something we have talked about a lot in this committee and which is meant to be in place, whereby senior executives become individually responsible in respect of bad practice and so forth. Would the witnesses have comments, within their answers to other representatives later, on the importance of us putting in place a senior executive accountability regime?

Also, could there be some clarity around the prescribed person? Sometimes there is ambiguity, whereby somebody is given something because he or she is the prescribed person, and then, when that person changes role, he or she says it was given to the role rather than to the person. When something is given to a prescribed person because of his or her role, is the disclosure regarded as having been given to the role or to the person? My understanding is that it would be the person when he or she was in that role. However, I have had ambiguous opinions given to me about that. I know others need to come in, so perhaps there may be a chance for the witnesses to come back on that later.

Comments

No comments

Log in or join to post a public comment.